Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Diagnostic and prognostic markers in gliomas
Current Opinion in Oncology, 10/13/09
Ducray F et al. – This review summarizes recent studies on diagnostic and prognostic markers in gliomas such as the BRAF fusion gene in pilocytic astrocytomas and 1p/19q codeletion, O–6–methylguanine–DNA methyltransferase status and isocitrate dehydrogenase 1 (IDH1)/IDH2 mutations in diffuse gliomas. Extensive molecular studies have enabled the discovery of new diagnostic and prognostic markers that are refining the histomolecular classification of gliomas.
Related Articles
Height, Body Mass Index, and Physical Activity in Relation to Glioma Risk
Cancer Research, 11/02/09
Relevance Score: 90%
Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches
Current Opinion in Neurology, 11/11/09
Relevance Score: 89%
Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy
International Journal of Cancer, 11/10/09
Relevance Score: 89%
The Metabolic Epicenter of Supratentorial Gliomas: A 1H-MRSI Study
Canadian Journal of Neurological Sciences, 11/04/09
Relevance Score: 89%
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
Journal of Clinical Oncology, 11/12/09
Relevance Score: 88%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Journal of Neuro-Oncology, 12/04/09
Seizure risk in brain tumor patients with conversion to generic levetiracetam
Journal of Neuro-Oncology, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


